Design, Synthesis, and Evaluation of Allosteric Effectors for Hemoglobin

NA Enakaya, A Jefferson… - Accounts of Chemical …, 2023 - ACS Publications
Conspectus Sickle cell disease (SCD) is an inherited blood disorder caused by a point
mutation in hemoglobin (Hb), the protein in the red blood cell (RBC) responsible for the …

Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen …

FC Wireko, GE Kellogg… - Journal of medicinal …, 1991 - ACS Publications
Background Human hemoglobin is an allosteric protein that equilibrates between the deoxy
or tense (T) state and the oxy or relaxed (R) state. Arrangement of the four subunits around a …

X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites

MK Safo, T Boyiri, JC Burnett… - … Section D: Biological …, 2002 - scripts.iucr.org
The rational design and X-ray crystallographic analyses of two symmetrical allosteric
effectors of hemoglobin (Hb) are reported. Compound design was directed by the previously …

New look at hemoglobin allostery

Y Yuan, MF Tam, V Simplaceanu, C Ho - Chemical reviews, 2015 - ACS Publications
Hemoglobin (Hb) is a truly remarkable molecule. Human adult hemoglobin (Hb A) has a
tetrameric structure consisting of two α-chains with 141 amino acids each and two β-chains …

Aryloxyalkanoic acids as non-covalent modifiers of the allosteric properties of hemoglobin

AM Omar, MA Mahran, MS Ghatge, FHA Bamane… - Molecules, 2016 - mdpi.com
Hemoglobin (Hb) modifiers that stereospecifically inhibit sickle hemoglobin polymer
formation and/or allosterically increase Hb affinity for oxygen have been shown to prevent …

Semihemoglobins, high oxygen affinity dimeric forms of human hemoglobin respond efficiently to allosteric effectors without forming tetramers

A Tsuneshige, K Kanaori, U Samuni, D Danstker… - Journal of Biological …, 2004 - ASBMB
Significant reduction in oxygen affinity resulting from interactions between heterotropic
allosteric effectors and hemoglobin in not only the unligated derivative but also the fully …

How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium

DJ Abraham, MK Safo, T Boyiri… - Biochemistry, 1995 - ACS Publications
Revised Manuscript Received June 27, 1995® abstract: Monoaldehyde allosteric effectors
of hemoglobin were designed, using molecular modeling software (GRID), to form a Schiff …

High–resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector

MK Safo, CM Moure, JC Burnett, GS Joshi… - Protein …, 2001 - Wiley Online Library
The crystal structure of human deoxy hemoglobin (Hb) complexed with a potent allosteric
effector (2‐[4‐[[(3, 5‐dimethylanilino) carbonyl] methyl] phenoxy]‐2‐methylpropionic acid) …

[PDF][PDF] Allosteric effectors of hemoglobin: past, present and future

MK Safo, S Bruno - Chemistry and biochemistry of oxygen therapeutics …, 2011 - akbara.ac.id
Hemoglobin (Hb) remains the most studied and understood example of an allosteric protein.
It exists in equilibrium between a tense or T state (unliganded or deoxygenated Hb) and a …

[PDF][PDF] Liganded hemoglobin structural perturbations by the allosteric effector L35

Q Chen, I Lalezari, RL Nagel, RE Hirsch - Biophysical journal, 2005 - cell.com
Effector binding to liganded hemoglobin (Hb) provides a new understanding of structural
determinants of Hb function. L35, a bezafibrate-related compound, is one of the more potent …